Published in J Infect Dis on May 01, 1992
Ocular Changes After Ivermectin - (DOLF IVM/Oncho) | NCT03517462
Safety and Efficacy of IDA for Onchocerciasis (DOLF IDA/Oncho) | NCT04188301
River blindness: a success story under threat? PLoS Med (2006) 2.55
Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A (1999) 1.91
DNA probes and PCR for diagnosis of parasitic infections. Clin Microbiol Rev (1995) 1.51
Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea. Eur J Clin Pharmacol (2006) 1.30
Y chromosome STR haplotypes and the genetic structure of U.S. populations of African, European, and Hispanic ancestry. Genome Res (2003) 1.30
Pathogenesis of onchocercal keratitis (River blindness). Clin Microbiol Rev (1999) 1.20
Population biology of human onchocerciasis. Philos Trans R Soc Lond B Biol Sci (1999) 1.20
Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev (2011) 1.18
Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis (2013) 1.02
Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations. Eur J Clin Pharmacol (2006) 1.01
Onchocerca volvulus: comparison of field collection methods for the preservation of parasite and vector samples for PCR analysis. Bull World Health Organ (1997) 0.94
Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment. Pharmacogenomics (2012) 0.93
Polymerase chain reaction pool screening used to compare prevalence of infective black flies in two onchocerciasis foci in northern Sudan. Am J Trop Med Hyg (2011) 0.93
Preliminary study on temporal variations in biting activity of Simulium damnosum s.l. in Abeokuta North LGA, Ogun State Nigeria. Parasit Vectors (2009) 0.83
Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study. Filaria J (2004) 0.80
Molecular epidemiology, phylogeny and evolution of the filarial nematode Wuchereria bancrofti. Infect Genet Evol (2014) 0.79
The epidemiology of lymphatic filariasis in Ghana, explained by the possible existence of two strains of Wuchereria bancrofti. Pan Afr Med J (2014) 0.78
Genomic diversity in Onchocerca volvulus and its Wolbachia endosymbiont. Nat Microbiol (2016) 0.77
CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea. Infect Genet Evol (2015) 0.75
Significant heterogeneity in Wolbachia copy number within and between populations of Onchocerca volvulus. Parasit Vectors (2017) 0.75
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis. Cochrane Database Syst Rev (2016) 0.75
Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity. PLoS Negl Trop Dis (2017) 0.75
Global data on blindness. Bull World Health Organ (1995) 12.05
Available data on blindness (update 1994) Ophthalmic Epidemiol (1995) 3.28
Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J Infect Dis (1995) 2.58
A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ (1986) 2.51
Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol (2002) 2.22
Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ (2002) 1.99
The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol (2002) 1.84
The avian malaria Plasmodium lophurae has a small number of heterogeneous ribosomal RNA genes. Nucleic Acids Res (1983) 1.84
The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop (1991) 1.76
ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed (1990) 1.70
Identification of bloodmeals in haematophagous Diptera by cytochrome B heteroduplex analysis. Med Vet Entomol (1999) 1.69
APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control. Ann Trop Med Parasitol (2002) 1.65
The mitochondrial genome of Onchocerca volvulus: sequence, structure and phylogenetic analysis. Mol Biochem Parasitol (1998) 1.59
Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis (1995) 1.58
Large scale ivermectin distribution and its epidemiological consequences. Acta Leiden (1990) 1.51
Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet (2004) 1.47
The force of measles infection in East Africa. Int J Epidemiol (1984) 1.45
Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution. Trans R Soc Trop Med Hyg (1995) 1.43
Characterization of the autoantigen calreticulin. J Immunol (1991) 1.42
Pseudouridines and pseudouridine synthases of the ribosome. Cold Spring Harb Symp Quant Biol (2001) 1.39
Ocular onchocerciasis and intensity of infection in the community. I. West African savanna. Trop Med Parasitol (1989) 1.38
Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ (1989) 1.37
The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol (2002) 1.35
The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Ann Trop Med Parasitol (1985) 1.26
Vitamin A deficiency in southern Ethiopia. Am J Clin Nutr (1987) 1.26
The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. Bull World Health Organ (1991) 1.24
Pool screen polymerase chain reaction for estimating the prevalence of Onchocerca volvulus infection in Simulium damnosum sensu lato: results of a field trial in an area subject to successful vector control. Am J Trop Med Hyg (1999) 1.22
The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg (1995) 1.21
Mosquito and arbovirus activity during 1997-2002 in a wetland in northeastern Mississippi. J Med Entomol (2004) 1.20
Sequence of a small ribosomal RNA gene from Plasmodium lophurae. Nucleic Acids Res (1989) 1.19
A DNA sequence specific for forest form Onchocerca volvulus. Nature (1987) 1.18
Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol (2002) 1.16
Genetic evidence for assortative mating between 13-year cicadas and sympatric "17-year cicadas with 13-year life cycles" provides support for allochronic speciation. Evolution (2000) 1.16
Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology (2002) 1.16
Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol (2002) 1.14
Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J Infect Dis (2001) 1.12
An A to U transversion at position 1067 of 23 S rRNA from Escherichia coli impairs EF-Tu and EF-G function. J Mol Biol (1997) 1.10
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. Br J Ophthalmol (1987) 1.10
Onchocerca volvulus: application of the polymerase chain reaction to identification and strain differentiation of the parasite. Exp Parasitol (1991) 1.09
The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa. Bull World Health Organ (1990) 1.08
Population dynamics of Onchocerca volvulus after 7 to 8 years of vector control in West Africa. Acta Trop (1987) 1.07
Epidemiological modelling for onchocerciasis control. Parasitol Today (1992) 1.06
A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. Trop Med Parasitol (1989) 1.06
Recent evolutionary history of American Onchocerca volvulus, based on analysis of a tandemly repeated DNA sequence family. Mol Biol Evol (1994) 1.05
Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol Biochem Parasitol (2006) 1.05
Analysis of apicoplast targeting and transit peptide processing in Toxoplasma gondii by deletional and insertional mutagenesis. Mol Biochem Parasitol (2001) 1.04
Onchocerca volvulus: genetic diversity of parasite isolates from Sudan. Exp Parasitol (2001) 1.03
Density-dependent processes in the transmission of human onchocerciasis: relationship between the numbers of microfilariae ingested and successful larval development in the simuliid vector. Parasitology (1995) 1.03
DNA probe-based classification of Simulium damnosum s. l.-borne and human-derived filarial parasites in the onchocerciasis control program area. Am J Trop Med Hyg (1994) 1.02
Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. Bull World Health Organ (1997) 1.02
Molecular approaches to the diagnosis of onchocerciasis. Adv Parasitol (1996) 1.02
Angiogenic activity of Onchocerca volvulus recombinant proteins similar to vespid venom antigen 5. Mol Biochem Parasitol (2000) 1.01
Patterns of epidemiology and control of onchocerciasis in west Africa. J Helminthol (1997) 1.01
Delivery systems and cost recovery in Mectizan treatment for onchocerciasis. Ann Trop Med Parasitol (1998) 1.00
The impact of Mectizan on the transmission of onchocerciasis. Ann Trop Med Parasitol (1998) 0.99
Detailed epidemiological mapping of three onchocerciasis foci in West Africa. Acta Trop (1991) 0.98
Novel mutants of 23S RNA: characterization of functional properties. Nucleic Acids Res (1992) 0.98
Impact of cattle on the prevalence and severity of trachoma. Br J Ophthalmol (1987) 0.97
Ocular onchocerciasis and intensity of infection in the community. II. West African rainforest foci of the vector Simulium yahense. Trop Med Parasitol (1989) 0.97
Intra-specific heterogeneity of the rDNA internal transcribed spacer in the Simulium damnosum (Diptera: Simuliidae) complex. Mol Biol Evol (1996) 0.96
The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Ann Trop Med Parasitol (1986) 0.96
Distribution and severity of onchocerciasis in southern Benin, Ghana and Togo. Acta Trop (1992) 0.96
Onchocerca volvulus: comparison of field collection methods for the preservation of parasite and vector samples for PCR analysis. Bull World Health Organ (1997) 0.94
Cytotaxonomic and molecular analysis of Simulium (Edwardsellum) damnosum sensu lato (Diptera: Simuliidae) from Abu Hamed, Sudan. J Med Entomol (2000) 0.94
Cloning and characterization of a potentially protective chitinase-like recombinant antigen from Wuchereria bancrofti. Infect Immun (1994) 0.94
Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis. Infect Immun (1994) 0.92
Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus. Trans R Soc Trop Med Hyg (1991) 0.91
Mutational analysis of two highly conserved UGG sequences of 23 S rRNA from Escherichia coli. J Biol Chem (1996) 0.90
Onchocerciasis distribution and severity in five West African countries. Bull World Health Organ (1991) 0.90
Prospective evaluation of onchocerciasis control strategies. Acta Leiden (1990) 0.90
Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea. Bull World Health Organ (1995) 0.90
Development and evaluation of a molecular viability assay for Pneumocystis carinii. J Clin Microbiol (2000) 0.89
Detection of Onchocerca volvulus infection by O-150 polymerase chain reaction analysis of skin scratches. J Infect Dis (1998) 0.89
Ribosomal protein L16 binds to the 3'-end of transfer RNA. FEBS Lett (1984) 0.89
A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions. Trop Med Parasitol (1989) 0.89
Onchocerciasis control: the APOC strategy. Afr Health (1997) 0.89
Vector-parasite transmission complexes for onchocerciasis in West Africa. Lancet (1997) 0.88
Base-pairing of 23 S rRNA ends is essential for ribosomal large subunit assembly. J Mol Biol (1998) 0.87
Characterization and expression of enzymatically active recombinant filarial prolyl 4-hydroxylase. Mol Biochem Parasitol (2001) 0.87
The Simulium damnosum species complex: phylogenetic analysis and molecular identification based upon mitochondrially encoded gene sequences. Insect Mol Biol (1995) 0.86
Onchocerca volvulus: limited heterogeneity in the nuclear and mitochondrial genomes. Exp Parasitol (1999) 0.86